ICD-10-CM Billable Code

M1A.47

Other secondary chronic gout, ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Chronic gout is a condition characterized by persistent joint inflammation caused by the accumulation of uric acid crystals. Specifically, when gout affects the ankle and foot in a secondary and long-lasting manner, it is classified under the ICD-10 code M1A.47. This form of gout often develops after multiple gout attacks or due to underlying health issues that influence uric acid levels. Over time, it can lead to joint damage and deformities if not properly managed, impacting mobility and quality of life.

Causes & Symptoms

Clinical Causes: Persistent elevated uric acid levels (hyperuricemia) due to metabolic disorders Use of certain medications, such as diuretics or low-dose aspirin Chronic kidney disease impairing uric acid excretion Obesity increasing uric acid production Genetic predispositions affecting uric acid metabolism Consumption of purine-rich foods like red meat, shellfish, and alcohol

Key Symptoms: Persistent pain and tenderness in the ankle and foot joints Swelling and inflammation that lasts for extended periods Presence of tophi (urate crystal deposits under the skin) around affected joints Joint stiffness and decreased mobility in the affected areas Skin redness and warmth over affected joints Potential joint deformities over time if untreated

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of medical history, physical examination, and laboratory tests. Key components include: - Synovial fluid analysis to identify uric acid crystals under a microscope - Blood tests to measure serum uric acid levels - Imaging studies, such as X-rays, to detect joint damage and tophi - Evaluation of underlying health conditions contributing to hyperuricemia These assessments help distinguish secondary chronic gout from other joint disorders and determine its extent.

Treatment Protocols: Managing secondary chronic gout focuses on controlling uric acid levels and alleviating symptoms. Common approaches include: - Medications such as urate-lowering agents (allopurinol, febuxostat) to prevent crystal formation - Anti-inflammatory drugs (NSAIDs, corticosteroids) to reduce joint inflammation during flare-ups - Colchicine to manage acute attacks - Lifestyle modifications like dietary changes, weight management, and limiting alcohol intake - Regular monitoring of uric acid levels to adjust treatment plans - Addressing underlying health issues, such as kidney disease or metabolic syndromes, to reduce uric acid production These strategies aim to decrease the frequency of gout attacks, prevent joint damage, and improve joint function.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.47 a billable ICD-10 code?
Yes, M1A.47 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.47?
Clinical documentation must specify the nature of Other secondary chronic gout, ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference